Key Events This Week
23 Mar: Sharp decline of 5.32% amid broad market sell-off
24 Mar: Recovery with 2.77% gain supported by positive market sentiment
25 Mar: Intraday high surge of 7.65%, closing at Rs.779.60 (+6.62%)
27 Mar: Mixed technical signals as stock gains 1.08% despite Sensex fall

Senores Pharmaceuticals Ltd Shows Mixed Technical Signals Amid Price Momentum Shift
2026-03-27 08:03:26Senores Pharmaceuticals Ltd has experienced a notable shift in price momentum, reflected in a 6.91% gain on 27 Mar 2026, moving the stock from a mildly bearish technical stance to a more sideways trend. This article analyses the latest technical indicators, including MACD, RSI, moving averages, and volume trends, to provide a comprehensive view of the stock’s current positioning within the Pharmaceuticals & Biotechnology sector.
Read full news article
Senores Pharmaceuticals Ltd Surges 7.65% to Day's High of Rs 787.15 — Outperforms Sector by 6 Percentage Points
2026-03-25 10:21:36The Sensex climbed 1.67% on 25 Mar 2026, yet Senores Pharmaceuticals Ltd outpaced the broader market with a 7.65% gain, reaching an intraday high of Rs 787.15. This 6-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift.
Read full news article
Senores Pharmaceuticals Ltd is Rated Hold
2026-03-18 10:10:03Senores Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall market standing.
Read full news article










